Argatroban
FDA Approved: * June 30, 2000Pharm Company: * ENCYSIVE
Category: Blood Thinner (Anticoagulant)
Argatroban is an anticoagulant that is a small molecule direct thrombin inhibitor.[2] In 2000, argatroban was licensed by the Food and Drug Administration (FDA) for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia (HIT). In 2002, it was approved for use during percutaneous coronary interventions in patients who have HIT or are at risk for developing it. In 2012, it was approved by the MHRA in the UK for anticoagulation in patients with... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Argatroban 100 mg/ml Intravenous Injection, Solution
NDC: 0078-0930
Labeler:
Novartis Pharmaceuticals Corporation
Argatroban 250 mg/2.5ml Intravenous Injection
NDC: 0143-9288
Labeler:
West-ward Pharmaceuticals Corp
Argatroban 1 mg/ml Intravenous Injection, Solution
NDC: 0703-0020
Labeler:
Teva Parenteral Medicines, Inc.